Literature DB >> 20200418

Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.

S C Kachlany1.   

Abstract

Aggregatibacter actinomycetemcomitans is a Gram-negative bacterium that colonizes the human oral cavity and is the causative agent for localized aggressive periodontitis (LAP), an aggressive form of periodontal disease that occurs in adolescents. A. actinomycetemcomitans secretes a protein toxin, leukotoxin (LtxA), which helps the bacterium evade the host immune response during infection. LtxA is a membrane-active toxin that specifically targets white blood cells (WBCs). In this review, we discuss recent developments in this field, including the identification and characterization of genes and proteins involved in secretion, regulation of LtxA, biosynthesis, newly described activities of LtxA, and how LtxA may be used as a therapy for the treatment of diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200418      PMCID: PMC3144085          DOI: 10.1177/0022034510363682

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  110 in total

Review 1.  Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review).

Authors:  I Barry Holland; Lutz Schmitt; Joanne Young
Journal:  Mol Membr Biol       Date:  2005 Jan-Apr       Impact factor: 2.857

Review 2.  Therapeutic potential of biofilm-dispersing enzymes.

Authors:  Jeffrey B Kaplan
Journal:  Int J Artif Organs       Date:  2009-09       Impact factor: 1.595

3.  TolC, an Escherichia coli outer membrane protein required for hemolysin secretion.

Authors:  C Wandersman; P Delepelaire
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma.

Authors:  E Olsen; M Duvic; A Frankel; Y Kim; A Martin; E Vonderheid; B Jegasothy; G Wood; M Gordon; P Heald; A Oseroff; L Pinter-Brown; G Bowen; T Kuzel; D Fivenson; F Foss; M Glode; A Molina; E Knobler; S Stewart; K Cooper; S Stevens; F Craig; J Reuben; P Bacha; J Nichols
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

5.  Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins.

Authors:  E T Lally; E E Golub; I R Kieba; N S Taichman; J Rosenbloom; J C Rosenbloom; C W Gibson; D R Demuth
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

6.  Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice.

Authors:  Richard Niederman; Hans Kelderman; Sigmund Socransky; Gary Ostroff; Caroline Genco; Ralph Kent; Philip Stashenko
Journal:  Arch Oral Biol       Date:  2002-08       Impact factor: 2.633

7.  Roles of TolC-dependent multidrug transporters of Escherichia coli in resistance to beta-lactams.

Authors:  Kunihiko Nishino; Junko Yamada; Hidetada Hirakawa; Takahiro Hirata; Akihito Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a beta-propeller for cytotoxicity.

Authors:  Irene R Kieba; Karen P Fong; Hsin-Yao Tang; Karl E Hoffman; David W Speicher; Lloyd B Klickstein; Edward T Lally
Journal:  Cell Microbiol       Date:  2007-06-24       Impact factor: 3.715

9.  Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.

Authors:  C C Tsai; B J Shenker; J M DiRienzo; D Malamud; N S Taichman
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

10.  Interaction between leukotoxin and Cu,Zn superoxide dismutase in Aggregatibacter actinomycetemcomitans.

Authors:  Nataliya V Balashova; Diane H Park; Jigna K Patel; David H Figurski; Scott C Kachlany
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

View more
  65 in total

Review 1.  Neutrophils in periodontal inflammation.

Authors:  David A Scott; Jennifer Krauss
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1.

Authors:  Kristina M DiFranco; Rajesh H Kaswala; Chandni Patel; Chinnaswam Kasinathan; Scott C Kachlany
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

3.  Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.

Authors:  Brian A Vega; Liam T Schober; Tami Kim; Benjamin A Belinka; Scott C Kachlany
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

4.  Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.

Authors:  Kristina M DiFranco; Anukriti Gupta; Lindsey E Galusha; Jarelys Perez; To-Vy K Nguyen; Camille D Fineza; Scott C Kachlany
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

5.  Editorial: leukocyte-targeting toxins as therapeutics in allergic asthma.

Authors:  Namit Sharma; Andrew W B Craig
Journal:  J Leukoc Biol       Date:  2015-03       Impact factor: 4.962

6.  Bacterial infection increases periodontal bone loss in diabetic rats through enhanced apoptosis.

Authors:  Sandra Pacios; Oelisoa Andriankaja; Jun Kang; Maher Alnammary; Jason Bae; Beatriz de Brito Bezerra; Helen Schreiner; Daniel H Fine; Dana T Graves
Journal:  Am J Pathol       Date:  2013-10-08       Impact factor: 4.307

7.  Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Authors:  Marianne Skals; Randi G Bjaelde; Jesper Reinholdt; Knud Poulsen; Brian S Vad; Daniel E Otzen; Jens Leipziger; Helle A Praetorius
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 8.  Polymicrobial synergy and dysbiosis in inflammatory disease.

Authors:  Richard J Lamont; George Hajishengallis
Journal:  Trends Mol Med       Date:  2014-11-20       Impact factor: 11.951

9.  Blue light kills Aggregatibacter actinomycetemcomitans due to its endogenous photosensitizers.

Authors:  Fabian Cieplik; Andreas Späth; Christoph Leibl; Anita Gollmer; Johannes Regensburger; Laura Tabenski; Karl-Anton Hiller; Tim Maisch; Gottfried Schmalz
Journal:  Clin Oral Investig       Date:  2013-12-03       Impact factor: 3.573

10.  Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans.

Authors:  Catherine Childress; Leigh A Feuerbacher; Linda Phillips; Alex Burgum; David Kolodrubetz
Journal:  J Bacteriol       Date:  2013-03-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.